skip to main content

    Updated Visitor Guidelines

 

MENU

 

Breast Cancer

Jill Martin’s breast cancer journey

TODAY show contributor Jill Martin was diagnosed and treated for breast cancer in 2023. Now, the University of Michigan alum has become an influential cancer advocate. In this Q&A, Jill shares what she wants people to know about her journey and the importance of early cancer screening.

How breast cancer cells survive in bone marrow after remission

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. The paper, “Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels,” appears in the Journal of Clinical Investigation.

Histotripsy can help release HER2 from cancer tumor cells

A revolutionary new therapy, called histotripsy uses soundwaves to destroy liver tumors and was approved for clinical use by the FDA in 2023. A recent study in the journal Cancers demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.

How to assess your risk for breast cancer

Many incorrectly estimate their risk, which affects their options for risk reduction

Many breast cancer survivors don't receive genetic testing, despite being eligible

Genetic testing results can inform cancer treatment, survivorship care and family members’ cancer risk

$25M gift to benefit patients at U-M's new Weiser Family Center for Breast Cancer, spur additional giving

Michigan Medicine launches a new era in comprehensive breast cancer care. A $25 million donation from the Weiser Charitable Foundation will support establishing the Weiser Family Center for Breast Cancer at the University of Michigan Rogel Cancer Center.

Drug-chemo combo increases breast cancer treatment efficacy

Preclinical models show that combining an inhibitor of a metabolic pathway with chemotherapy could improve outcomes in triple-negative breast cancer brain metastases.

Pages